4//SEC Filing
Fischesser Ryan 4
Accession 0001209191-21-070797
CIK 0001619856other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 5:23 PM ET
Size
10.0 KB
Accession
0001209191-21-070797
Insider Transaction Report
Form 4
Fischesser Ryan
VP of Finance and Controller
Transactions
- Purchase
Common Stock
2021-12-20$2.69/sh+1,136$3,056→ 101,695 total - Award
Option to purchase Common Stock
2021-12-20+40,000→ 40,000 totalExercise: $15.16Exp: 2031-12-19→ Common Stock (40,000 underlying) - Exercise of In-Money
Option to purchase Common Stock
2021-12-20−1,136→ 7,384 totalExercise: $2.69Exp: 2029-03-18→ Common Stock (1,136 underlying)
Footnotes (4)
- [F1]These shares were acquired pursuant to the exercise of a stock option, as reported in Table II below.
- [F2]The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021.
- [F3]The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on January 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
- [F4]The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on December 20, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
Documents
Issuer
Caribou Biosciences, Inc.
CIK 0001619856
Entity typeother
Related Parties
1- filerCIK 0001871155
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 5:23 PM ET
- Size
- 10.0 KB